Innovation in diagnostics and treatment of epilepsy
Year: 2017, volume 13 Issue: №1 Pages: 143-147
Heading: Neurology Article type: Review
Authors: Kalinin V.A., Poverennova I.E., Yakunina A.V., Beketova E.M.
Organization: Samara State Medical University, Municipal Hospital No. 1 n.a. N. I. Pirogov, Samara
Heading: Neurology Article type: Review
Authors: Kalinin V.A., Poverennova I.E., Yakunina A.V., Beketova E.M.
Organization: Samara State Medical University, Municipal Hospital No. 1 n.a. N. I. Pirogov, Samara
Summary:
The aim of the review is try to systematize the innovative achievements of modern epileptology and indicate the levels of diagnosis and treatment of epilepsy that are not sufficiently developed, from our point of view. Applied to epileptology, the innovation process is realized at all levels. In principle, you can divide the entire process into a diagnostic and treatment level. Promising in the diagnosis of epilepsy should be considered the analysis of age characteristics, new methods of EEG analysis and evoked potentials, innovative methods of functional neuroimaging, genetic testing. New anticonvulsants with the original mechanism of action allow to overcome pharmaco-resistance of epilepsy in a number of observations. In rare cases it is necessary to use minimally invasive surgical methods of treatment.
Bibliography:
1. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005 Apr; 46 (4): 470-2. [Medline]
2. Karlov VA, Inosemtseva OS. Analysis of adult patients with epilepsy in the age continuum. Neurology, Neuropsychiatry Psychosomatics 2016; (1S): 38-40
3. Kalinin VA, Yakunina AV, Poverennova IE. Regularities in the course of epilepsy during various age periods. Neurology Neuropsychiatry, Psychosomatics 2015; (S1): 26-30
4. Benbadis SR, Chen S, Melo M. What's shaking in the ICU? The differential diagnosis of seizures in the intensive care setting. Epilepsia 2010 Nov; 51 (11): 2338-40. [Medline]
5. Kalinin VA, Poverennova IE, BeketovaEM,Gromakovskaya MA. Mathematical modeling of epileptogenesis process in different age groups. Epilepsy and Paroxysmal States 2016; 8 (3): 74-83
6. Commission on Neuroimaging of the International League Against Epilepsy. Recommendations for neuroimaging of patients with epilepsy. Epilepsia 1997 Nov; 38 (11): 1255-6. [Medline]
7. Stylianou P, Kimchi G, Hoffmann C, Blat I, Harnof S. Neuroimaging for patient selection for medial temporal lobe epilepsy surgery: Part 2 functional neuroimaging. J Clin Neurosci. 2015 Oct 6. [Medline]
8. Wieshmann UC. Clinical application of neuroimaging in epilepsy. J Neurol Neurosurg Psychiatry 2003 Apr; 74 (4): 466-70. [Medline]. [Full Text]
9. Ramli N, Rahmat K, Lim KS, Tan CT. Neuroimaging in refractory epilepsy. Current practice and evolving trends. Eur J Radiol 2015 Sep; 84 (9): 1791-800. [Medline]
10. Stefan H, Hummel C, Scheler G, Genow A, Druschky K, Tilz C, et al. Magnetic brain source imaging of focal epileptic activity: a synopsis of 455 cases. Brain 2003 Nov; 126: 2396-405. [Medline]
11. Belousova ED. Genetics of Epilepsy: What for and How to Examine Children with Epilepsy. Neurology, Neuropsychiatry Psychosomatics 2014; 6 (1S): 4-8
12. Kukes VG, Sychev DA. Personalized Medicine: New Opportunities for Improving the Safety of Pharmacotherapy Remedium 2010; (1): 38-40
13. Veldiaksova ED, Yakunina AV, Pisar AA. Modern capabilities of personalized prescription antiepileptic drug. The Journal of Scientific Articles "Health and Education Millennium" 2017; 19 (4): 56-61
14. Kwan Р, Brodie MJ. Early identification of refractory epilepsy. N Engel J Med. 2000 Feb 3; 342 (5): 314-9. [Medline]
15. Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, et al. Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology 2012 Jan 10; 78 (2): 139-45. [Medline]
16. French J, Krauss G, Steinhoff B, et al. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305. Epilepsia 2012; 54 (1): 117-125 DOI: 10.1111/j.1528-1167.2012.03638.x
17. Zhidkova A, Karlov VA, Vlasov PN. Perampanel in pharmacotherapy of focal epilepsy: the efficacy and tolerability in routine clinical practice. Neuroscience and Behavioral Physiology 2016; 116 (9-2): 82-88
18. Heyman Е, Lahat Е, Levin N, Berkovitch М, Gandelman-Marton R. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy. Eur J Paediatr Neurol 2012 Jan; 16(1): 15-9. [Medline]
19. Afra P, Adamolekun B. Lacosamide treatment of juvenile myoclonic epilepsy. Seizure 2012 Apr; 21 (3): 202-4. [Medline].
20. Curry DJ, Gowda A, McNichols RJ, Wilfong AA. MR-guided stereotactic laser ablation of epileptogenic foci in children. Epilepsy Behav 2012; 24: 408-414. Abstract.
| Attachment | Size |
|---|---|
| 2017_01-1_143-147.pdf | 242.49 KB |
Русский
English